Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Phase II-III Clinical Trials
Vaccine Phase II-III Trials
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 36 posts
Factsheet
27 Sep 2019
A Key Endpoint in Viral Challenge Models of Asthma Exacerbations
Human Rhinovirus (HRV) is reported to be a leading cause of up to 80% of asthma exacerbations. The viral pathway and associated immune responses represent a potential key therapeutic target...
Read more
Presentation
25 Sep 2019
Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model
hVIVO's presentation during the Options X conference in 2019 about pre-existing NP specific T-cell response correlates with reduction of symptoms in a human influenza challenge model.
Read more
Factsheet
23 Sep 2019
The Human Viral Challenge Model with A/PERTH/16/2009 H3N2A systematic analysis from five clinical studies
The human viral challenge model is well established, safe and ideal to study influenza. It allows researchers to illuminate each step of the infection: baseline, peak and return to healthy....
Read more
11 Apr 2019
hVIVO is Gold Sponsor and presenter at World Vaccine Congress, Washington DC, USA April 2019
WVC 2017, 14-17 April 2019, Renaissance Washington DC Downtown Hotel, Washington DC, USA hVIVO is proud to once again be a Gold Sponsor of the World Vaccine Congress 2019, a...
Read more
02 Apr 2019
hVIVO and Imutex Limited to present at IVW 2019 conference, Edinburgh, Scotland, April
Influenza Vaccines For The World 2019, April 02 - 04, Edinburgh, Scotland. hVIVO and its joint venture, Imutex Limited, will present at the Influenza Vaccines for the World (IVW 2019)...
Read more
18 Mar 2019
hVIVO's Alex Mann making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting, Siena, Italy, March
ISRIV 1st Influenza Vaccine Group Meeting, March 31st - April 2nd, Siena, Italy Alex Man, hVIVO’s Director Clinical Science R&D Operations, will be making an oral presentation at ISRIV 1st Influenza...
Read more
Article Pagination
1
2
3
4
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down